Japan Negotiates To Cancel Orders For 99 Million Flu Vaccine Doses
This article was originally published in PharmAsia News
Executive Summary
Japan is attempting to cancel 99 million doses of H1N1 flu vaccine it ordered by negotiating with two major makers, the U.K.'s GlaxoSmithKline and Switzerland's Novartis